Rare Disease Resources Every Pharma and Biotech Company Should Know
- Global Genes – connects, empowers, and inspires the rare disease community through education, advocacy, and legislative advocacy.
- RareX – a global data-sharing platform that enables rare patient communities to more easily gather, structure, and securely share critical data
- EveryLife Foundation– empowers the rare disease patient community to advocate for impactful, science-driven legislation and policy that advances the equitable development of and access to lifesaving diagnoses, treatments, and cures.
- NORD – a patient advocacy organization dedicated to individuals with rare diseases and the organizations that serve them. NORD, along with its more than 300 patient organization members, is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and patient services
- The Disorder Channel – a compilation of rare disease films offered free on Roku and Amazon Fire TV. It’s virtually impossible to watch these stories and walk away without a heart full of empathy and compassion for all a rare disease patient or caregiver struggles with – and overcomes – during the journey.
On Rare Disease Day – and every day – our hope is that our industry continues our collective pursuit of improving the lives of patients living with rare diseases using these resources and other methods. Contact us today if we can assist your team in better understanding and ensuring access and support for rare disease patients.
Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.
Share in
Recent Posts
FDA Extends Compliance Deadline for Updated DSCSA Requirements
Understanding the revised timeline for compliance with specific updated DSCSA requirements
Are Direct-to-Patient Access Models the Future of Pharma?
Understanding the opportunity to sell directly to patients via a cash model
Key Takeaways from NASP 2024
The 2024 National Association of Specialty Pharmacy (NASP) conference showcased a landscape of rapid innovation and evolving industry trends.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|